About: http://webisa.webdatacommons.org/218441055

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	This study is a Phase 1 and pharmacologic open-labeled dose-escalation trial using a 3+3 design, evaluating MM-151 at varying dose levels and frequencies, and subsequently in combination with irinotecan.
http://www.w3.org/ns/prov#wasQuotedFrom	clinicaltrials.gov